Cover Image
市場調查報告書

兒童介入性心臟學的全球市場 - 先天性心臟病(心房中隔缺損,心室中隔缺損,動脈管開存,左心耳,主動脈瓣,肺動脈瓣)封閉設備及手術市場預測

Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts to 2018

出版商 MarketsandMarkets 商品編碼 298538
出版日期 內容資訊 英文 237 Pages
訂單完成後即時交付
價格
Back to Top
兒童介入性心臟學的全球市場 - 先天性心臟病(心房中隔缺損,心室中隔缺損,動脈管開存,左心耳,主動脈瓣,肺動脈瓣)封閉設備及手術市場預測 Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts to 2018
出版日期: 2014年03月25日 內容資訊: 英文 237 Pages
簡介

兒童介入性心臟學市場由於病例的增加及設備、治療技術的進步等推動要素,預測今後數年將健全成長。

本報告以這個兒童介入性心臟學全球市場為焦點,以今後到2018年這段期間為對象,就治療設備及地區別預測其轉變,再加上供需現況及趨勢的概述,彙整該產業的發展推動與阻礙要素及機會、競爭環境,市場佔有率,再加上主要企業簡介等分析·調查資訊,為您概述為以下內容。

第1章 簡介

  • 調查的目的
  • 報告的內容說明
  • 調查對象市場
  • 報告的對象用戶層
  • 範圍
  • 調查方法
    • 市場規模推算
    • 市場區隔與資料三角分析法
    • 市場佔有率的估計
    • 由一級資訊來源得來的資料重點
    • 由二級資訊來源得來的資料重點
    • 前提條件

第2章 摘要整理

第3章 值得一提的考察點

  • 投資趨勢
  • 技術趨勢
  • 法規環境
    • 兒童心血管治療設備的公共認證手續
    • 智慧財產權保護和專利訴訟
  • 醫療報酬狀況:經導管心臟瓣膜
  • 波特的五力分析
  • 未滿足需求
    • 幼兒專用的心血管治療設備
  • 成功的必需條件
    • 研究開發投資
    • 產業收購

第4章 市場概要

  • 市場動態
    • 市場推動要素
      • 兒童心血管介入設備
        • 政府支援是推動兒童介入心臟病學市場的因素
        • 提高大眾認知的計劃和會議推動了市場
        • 先天性心臟病(CHD)病例的增加加速了兒童介入心臟病學市場的發展
        • 技術進步拓展了設備製造商的新機會
        • 微創療法對傳統手術的優勢對市場成長有所貢獻
      • 兒童心血管影像技術
        • 支援兒童介入心臟病學影像技術市場的FDA(美國食品藥物管理局)配合措施
    • 阻礙市場要素
      • 兒童心血管介入設備
        • 複雜的認證申請手續
        • 嚴格又缺乏一貫性的申請手續延了新產品的上市
      • 兒童心血影像技術
        • 美國政府的課稅
    • 市場機會
      • 兒童心血管介入設備
        • 兒童心血管治療設備的進步
        • 亞太地區帶來莫大的成長機會
        • 經導管心臟瓣膜市場穩定成長
      • 兒童心血管影像技術
        • 行動導管檢驗室-下一代的潛力領域
    • 課題
      • 兒童心血管介入設備
        • 兒童臨床實驗的困難
      • 兒童心血管影像技術
        • 高額的兒童介入心臟病學影像設備
        • 小規模及新加入企業的存亡
  • 市場佔有率分析
    • 結構性心臟病封閉設備
    • 經導管心臟瓣膜

第5章 兒童介入心臟病學手術

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第6章 兒童心血管介入設備市場

  • 簡介
  • 心臟缺損封閉治療設備
    • 心房中隔缺損(ASD),心室中隔缺損(VSD),卵圓孔未閉合(PFO)封閉治療設備
    • 開放性動脈(PDA)封閉治療設備
    • 左心耳(LAA)封閉治療設備
  • 經導管心臟瓣膜
    • 經導管肺動脈瓣
    • 經導管主動脈瓣(TAV)
  • 其他
    • 血管成形術用氣球
    • 血管成形術用支架
    • 導管
    • 導管導引線

第7章 地區分析

  • 簡介
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他歐洲各國
  • 北美
    • 美國
    • 加拿大
  • 亞太地區
  • 其他地區

第8章 競爭環境

  • 兒童介入心臟病學影像技術市場
    • 簡介
    • 新產品銷售
    • 產業收購
    • 協定
    • 產業進出
    • 授權
  • 兒童心血管介入設備市場
    • 簡介
    • 產業收購
    • 協定
    • 新產品銷售
    • 其他的發展
    • 授權

第9章 企業簡介(概要,財務,產品與服務,策略,企業發展)

  • 影像技術產品
    • Ge Healthcare (Subsidiary of General Electric Company)
    • Siemens Healthcare (Subsidiary of Siemens AG)
    • 東芝
  • 兒童心血管介入設備廠商
    • Edwards Lifesciences
    • Gore Medical (Subsidiary of W.L. Gore & Associates)
    • Medtronic, Inc.
    • St. Jude Medical
    • Abbott Vascular (A Subsidiary of Abbott Laboratories)
    • Boston Scientific Corporation
    • Cordis Corporation (Subsidiary of Johnson & Johnson)
    • Numed, Inc.

※括號內項目並未網羅所有非上市企業資料

圖表一覽

目錄
Product Code: MD 2296

The global pediatric interventional cardiology market is a very dynamic market, as this market is witnessing a number of technological advancements, owing to which various new devices are being launched in the market. Traditionally, pediatric interventional cardiology was used for diagnostic purposes; however, currently, it is increasingly being used for treatment purposes as well. The transcatheter heart valve market is the fastest growing segment in the pediatric interventional cardiology market. In 2010, the first pediatric specific transcatheter pulmonary heart valve was launched in the U.S. market. Companies in this market are engaged in the development of new and improved transcatheter heart valves, which is a major reason for its high growth. In addition, this market is witnessing a number of venture capitalist investments, which is aiding in the development and launch of new products in this market.

In the coming years, the APAC and RoW regions are expected to grow at high CAGRs. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets in the pediatric interventional cardiology market. Both these regions offer a high growth potential as compared to mature markets such as Europe. Growth in these markets is spurred by the growing incidence of congenital heart disease (CHD). According to the American College of Cardiology Foundation, in 2010, the prevalence of CHD in Asia was 8.9 to 9.7 per 1,000 live births, whereas in Africa this figure was 1.1 to 3.5 per 1,000 live births. The APAC region is witnessing a number of collaborations between local players and foreign companies for the development of new products. Also, the APAC region is hosting a number of conferences and workshops for discussing new and advanced techniques that are present in the market. These conferences and workshops will help in stimulating innovation in the field of pediatric interventional cardiology, thus aiding the market to grow further.

The global pediatric interventional cardiology market is highly competitive and all the existing players in this market are engaged in developing new and advanced products, to maintain their market share. However, varied stringency of regulatory procedures across the globe and the presence of complex regulatory procedures are the factors that are likely to hinder the growth of this market. At present, difficulties encountered in clinical trials of pediatric medical devices such as patient recruitment and high cost are the major challenges faced by market players.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauze the pulse of the market, which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping a greater market share.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios and services offered by the top players in the pediatric interventional cardiology market. The report also provides the number of cath labs and the number of pediatric cardiology procedures performed across geographies
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the pediatric interventional cardiology market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the promising applications of pediatric interventional cardiology devices across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pediatric interventional cardiology market
  • Competitive Assessment: In depth assessment of market shares, strategies, products and services, distribution networks, manufacturing capabilities of leading players, and porters five forces analysis in the pediatric interventional cardiology market

Table of Contents

1 Introduction

  • 1.1 Objectives of the Study
  • 1.2 Report Description
  • 1.3 Markets Covered
  • 1.4 Stakeholders
  • 1.5 Scope
  • 1.6 Research Methodology
    • 1.6.1 Market Size Estimation
    • 1.6.2 Market Crackdown & Data Triangulation
    • 1.6.3 Market Share Calculation
    • 1.6.4 Key Data Points from Primary Sources
    • 1.6.5 Key Data Points from Secondary Sources
    • 1.6.6 Assumptions

2 Executive Summary

3 Premium Insights

  • 3.1 Investment Trends
  • 3.2 Technology Trends
  • 3.3 Regulatory Environment
    • 3.3.1 Regulatory Approval Procedures for Pediatric Cardiology Devices
      • 3.3.1.1 510(K) Application
      • 3.3.1.2 Premarket Approval (Pma) Application
      • 3.3.1.3 Humanitarian Device Exemption (Hde) Application
    • 3.3.2 Intellectual Property Protection and Patent Litigation
  • 3.4 Reimbursement Scenario: Transcatheter Heart Valves
  • 3.5 Porter's Five Forces Analysis: Pediatric Interventional Cardiology Imaging Market
    • 3.5.1 Threat of New Entrants
    • 3.5.2 Bargaining Power of Suppliers
    • 3.5.3 Bargaining Power of Buyers
    • 3.5.4 Competitor Rivalry
    • 3.5.5 Threat of Substitutes
  • 3.6 Unmet Need
    • 3.6.1 Pediatric-Specific Cardiac Devices
  • 3.7 Winning Imperatives
    • 3.7.1 Investments in R&D Activities
    • 3.7.2 Acquisitions

4 Market Overview

  • 4.1 Market Dynamics
    • 4.1.1 Market Drivers
      • 4.1.1.1 Pediatric Interventional Cardiology Devices
        • 4.1.1.1.1 Government Support, An Impetus for the Pediatric Interventional Cardiology Market
        • 4.1.1.1.2 Awareness Programs and Conferences to Fuel the Market
        • 4.1.1.1.3 Rising Incidences of Congenital Heart Defects(CHD)to Propel the Pediatric Interventional Cardiology Market
        • 4.1.1.1.4 Technological Advancements to Open New Opportunities for Device Manufacturers
        • 4.1.1.1.5 Advantages of Minimally Invasive Procedures Over Conventional Surgeries to Propel the Market Growth
      • 4.1.1.2 Pediatric Cardiology Imaging
        • 4.1.1.2.1 Fda's Efforts to Bolster the Pediatric Cardiology Imaging Market
    • 4.1.2 Market Restraints
      • 4.1.2.1 Pediatric Interventional Cardiology Devices
        • 4.1.2.1.1 Complex Regulatory Procedures
        • 4.1.2.1.2 Varied Stringency of Regulatory Procedures Delays Product Launches
      • 4.1.2.2 Pediatric Cardiology Imaging
        • 4.1.2.2.1 Implementation of Excise Tax By the U.S. Government
    • 4.1.3 Market Opportunities
      • 4.1.3.1 Pediatric Interventional Cardiology Devices
        • 4.1.3.1.1 Advances In Biodegradable Devices for Pediatric Cardiology
        • 4.1.3.1.2 Asia-Pacific Region Presents Significant Growth Opportunities
        • 4.1.3.1.3 Robust Growth in the Transcatheter Heart Valves Market
      • 4.1.3.2 Pediatric Cardiology Imaging
        • 4.1.3.2.1 Mobile Cath Labs, An Upcoming Opportunity Area
    • 4.1.4 Challenges
      • 4.1.4.1 Pediatric Interventional Cardiology Devices
        • 4.1.4.1.1 Difficulties in Pediatric Clinical Trials
      • 4.1.4.2 Pediatric Cardiology Imaging
        • 4.1.4.2.1 High Cost of Pediatric Interventional Cardiology Imaging Devices
        • 4.1.4.2.2 Survival of Small Players and New Entrants
  • 4.2 Market Share Analysis
    • 4.2.1 Structural Heart Defect Closure Devices
    • 4.2.2 Transcatheter Heart Valves

5 Pediatric Interventional Cardiology Procedures

  • 5.1 Introduction
  • 5.2 North America
  • 5.3 Europe
  • 5.4 APAC
  • 5.5 ROW

6 Pediatric Interventional Cardiology Devices Market

  • 6.1 Introduction
  • 6.2 Heart Defect Closure Devices
    • 6.2.1 ASD, VSD, & PFO Closure Devices
      • 6.2.1.1 Atrial Septal Defect (ASD) Closure Devices
      • 6.2.1.2 Ventricular Septal Defect (VSD) Closure Devices
      • 6.2.1.3 Patent Foramen Ovale (PFO) Closure Devices
    • 6.2.2 Patent Ductus Arteriosus (Pda) Closure Devices
    • 6.2.3 Left Atrial Appendage (Laa) Closure Devices
  • 6.3 Transcatheter Heart Valves
    • 6.3.1 Transcatheter Pulmonary Valves
    • 6.3.2 Transcatheter Aortic Valves (TAV)
  • 6.4 Others
    • 6.4.1 Angioplasty Balloons
    • 6.4.2 Angioplasty Stents
    • 6.4.3 Catheters
    • 6.4.4 Guidewires

7 Geographic Analysis

  • 7.1 Introduction
  • 7.2 Europe
    • 7.2.1 Germany
    • 7.2.2 France
    • 7.2.3 U.K.
    • 7.2.4 Italy
    • 7.2.5 Spain
    • 7.2.6 Roe
  • 7.3 North America
    • 7.3.1 U.S.
    • 7.3.2 Canada
  • 7.4 Asia-Pacific (APAC)
  • 7.5 Rest of the World (ROW)

8 Competitive Landscape

  • 8.1 Pediatric Interventional Cardiology Imaging Market
    • 8.1.1 Introduction
    • 8.1.2 New Product Launches
    • 8.1.3 Acquisitions
    • 8.1.4 Agreements
    • 8.1.5 Expansions
    • 8.1.6 Approvals
  • 8.2 Pediatric Interventional Cardiology Devices Market
    • 8.2.1 Introduction
    • 8.2.2 Acquisitions
    • 8.2.3 Agreements
    • 8.2.4 New Product Launches
    • 8.2.5 Other Developments
    • 8.2.6 Approvals

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 9.1 Imaging Products Companies
    • 9.1.1 Ge Healthcare (Subsidiary of General Electric Company)
    • 9.1.2 Siemens Healthcare (Subsidiary of Siemens AG)
    • 9.1.3 toshiba Corporation
  • 9.2 Pediatric Interventional Cardiology Device Companies
    • 9.2.1 Edwards Lifesciences
    • 9.2.2 Gore Medical (Subsidiary of W.L. Gore & Associates)
    • 9.2.3 Medtronic, Inc.
    • 9.2.4 St. Jude Medical
    • 9.2.5 Abbott Vascular (A Subsidiary of Abbott Laboratories)
    • 9.2.6 Boston Scientific Corporation
    • 9.2.7 Cordis Corporation (Subsidiary of Johnson & Johnson)
    • 9.2.8 Numed, Inc.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables

  • Table 1 Pediatric Interventional Cardiology Devices Market, By Geography, 2011-2018 ($Million)
  • Table 2 Number of Pediatric Interventional Cardiology Procedures, By Geography, 2012-2018
  • Table 3 Global Market, By Device Type, 2011-2018 ($Million)
  • Table 4 Pediatric Interventional Cardiology Devices Market, By Geography, 2011-2018 ($Million)
  • Table 5 North America: Pediatric Interventional Cardiology Devices Market, By Country, 2011-2018 ($Million)
  • Table 6 Europe: Pediatric Interventional Cardiology Devices Market, By Country, 2011-2018 ($Million)
  • Table 7 Heart Defect Closure Devices Market, By Device Type, 2011-2018 ($Million)
  • Table 8 Heart Defect Closure Devices Market, By Geography, 2011-2018 ($Million)
  • Table 9 North America: Heart Defect Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 10 Europe: Heart Defect Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 11 Pediatric ASD, VSD, & PFO Closure Devices Market, By Geography, 2011-2018 ($Million)
  • Table 12 North America: Pediatric ASD, VSD, & PFO Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 13 Europe: Pediatric ASD, VSD, & PFO Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 14 Major Atrial Septal Devices
  • Table 15 Major Ventricular Septal Defect Closure Devices
  • Table 16 Major Patent Foramen Ovale Closure Devices
  • Table 17 Major Patent Ductus Arteriosus Closure Devices
  • Table 18 Pediatric Pda Closure Devices Market, By Geography, 2011-2018 ($Million)
  • Table 19 North America: Pediatric Pda Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 20 Europe: Pediatric Pda Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 21 Major Left Atrial Appendage Closure Devices
  • Table 22 Pediatric Laa Closure Devices Market, By Geography, 2011-2018 ($Million)
  • Table 23 North America: Pediatric Laa Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 24 Europe: Pediatric Laa Closure Devices Market, By Country, 2011-2018 ($Million)
  • Table 25 Transcatheter Heart Valves Market, By Device Type, 2011-2018 ($Million)
  • Table 26 Transcatheter Heart Valves Market, By Geography, 2011-2018 ($Million)
  • Table 27 North America: Transcatheter Heart Valves Market, By Country, 2011-2018 ($Million)
  • Table 28 Europe: Transcatheter Heart Valves Market, By Country, 2011-2018 ($Million)
  • Table 29 Major Transcatheter Pulmonary Valve
  • Table 30 Pediatric Transcatheter Pulmonary Valve Device Market, By Geography, 2011-2018 ($Million)
  • Table 31 North America: Transcatheter Pulmonary Valves Market, By Country, 2011-2018 ($Million)
  • Table 32 Europe: Transcatheter Pulmonary Valves Market, By Country, 2011-2018 ($Million)
  • Table 33 Major Transcatheter Aortic Valves
  • Table 34 Pediatric Transcatheter Aortic Valve Device Market, By Geography, 2011-2018 ($Million)
  • Table 35 North America: Transcatheter Aortic Valves Market, By Country, 2011-2018 ($Million)
  • Table 36 Europe: Transcatheter Aortic Valves Market, By Country, 2011-2018 ($Million)
  • Table 37 Other Devices Market, By Geography, 2011-2018 ($Million)
  • Table 38 North America: Other Devices Market, By Country, 2011-2018 ($Million)
  • Table 39 Europe: Other Devices Market, By Country, 2011-2018 ($Million)
  • Table 40 Pediatric Interventional Cardiology Devices Market, By Geography, 2011-2018 ($Million)
  • Table 41 Europe: Market, By Device Type, 2011-2018 ($Million)
  • Table 42 Germany: Market, By Device Type, 2011-2018 ($Million)
  • Table 43 France: Market, By Device Type, 2011-2018 ($Million)
  • Table 44 U.K.: Market, By Device Type, 2011-2018 ($Million)
  • Table 45 Italy: Market, By Device Type, 2011-2018 ($Million)
  • Table 46 Spain: Market, By Device Type, 2011-2018 ($Million)
  • Table 47 Rest of Europe: Market, By Device Type, 2011-2018 ($Million)
  • Table 48 North America: Market, By Device Type, 2011-2018 ($Million)
  • Table 49 U.S.: Market, By Device Type, 2011-2018 ($Million)
  • Table 50 Canada: Market, By Device Type, 2011-2018 ($Million)
  • Table 51 Asia-Pacific (APAC): Market, By Device Type, 2011-2018 ($Million)
  • Table 52 ROW: Market, By Device Type, 2011-2018 ($Million)
  • Table 53 New Product Launch, 2011-2013
  • Table 54 Acquisitions, 2011-2013
  • Table 55 Agreements, 2011-2013
  • Table 56 Expansions, 2011-2013
  • Table 57 Approvals, 2011-2013
  • Table 58 Acqusitions, 2011-2013
  • Table 59 Agreements, 2011-2013
  • Table 60 New Product Launch, 2011-2013
  • Table 61 Other Developments, 2011-2013
  • Table 62 Approvals, 2011-2014
  • Table 63 General Electric: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 64 General Electric: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 65 General Electric: Total Revenue, By Geography, 2011-2013 ($Billion)
  • Table 66 Siemens Healthcare: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 67 Siemens Healthcare: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 68 Siemens Healthcare: Total Revenue, By Geography, 2011-2013 ($Million)
  • Table 69 Toshiba Corporation: Total Revenue and R&D Expenditure, 2011-2013 ($Billion)
  • Table 70 Toshiba Corporation: Total Revenue, By Segment, 2011-2013 ($Billion)
  • Table 71 Toshiba Corporation: Total Revenue, By Geography, 2011-2013 ($Billion)
  • Table 72 Edwards Lifesciences: Total Revenue and R&D Expenditure, 2010-2012 ($Million)
  • Table 73 Edwards Lifesciences: Total Revenue, By Segment, 2010-2012 ($Million)
  • Table 74 Edwards Lifesciences: Total Revenue, By Geography, 2010-2012 ($Million)
  • Table 75 Medtronic, Inc.: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 76 Medtronic, Inc.: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 77 Medtronic, Inc.: Total Revenue, By Geography, 2011-2013 ($Million)
  • Table 78 St. Jude Medical: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 79 St. Jude Medical: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 80 St. Jude Medical: Total Revenue, By Geography, 2011-2013 ($Million)
  • Table 81 Abbott Laboratories: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 82 Abbott Laboratories: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 83 Abbott Laboratories: Total Revenue, By Geography, 2011-2013 ($Million)
  • Table 84 Boston Scientific Corporation: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 85 Boston Scientific Corporation: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 86 Boston Scientific Corporation: Total Revenue, By Geography, 2011-2013 ($Million)
  • Table 87 Johnson & Johnson: Total Revenue and R&D Expenditure, 2011-2013 ($Million)
  • Table 88 Johnson & Johnson: Total Revenue, By Segment, 2011-2013 ($Million)
  • Table 89 Johnson & Johnson: Medical Devices and Diagnostic Segment Revenue, By Segment, 2011-2013 ($Million)
  • Table 90 Johnson & Johnson: Medical Devices and Diagnostic Segment Revenue, By Geography, 2011-2013 ($Million)

List of Figures

  • Figure 1 Forecast Model
  • Figure 2 Market Size Estimation Methodology
  • Figure 3 Data Triangulation
  • Figure 4 Number of Pediatric Interventional Cardiology Procedures, 2012-2018
  • Figure 5 Major Patent Infringement Cases
  • Figure 6 Porter's Five Forces Analysis
  • Figure 7 Market Dynamics
  • Figure 8 Structural Heart Defect Closure Devices Market Share Analysis, By Key Players, 2012
  • Figure 9 Transcatheter Heart Valve Market Share Analysis, By Key Player, 2012
  • Figure 10 Number of Pediatric Interventional Cardiology Procedures & Prevalence of CHD, By Geography, 2012-2018
  • Figure 11 North America: Number of Pediatric Interventional Cardiology Procedures, 2012-2018
  • Figure 12 Europe: Number of Pediatric Interventional Cardiology Procedures, 2012-2018
  • Figure 13 APAC: Number of Pediatric Interventional Cardiology Procedures, 2012-2018
  • Figure 14 ROW: Number of Pediatric Interventional Cardiology Procedures, 2012-2018
  • Figure 15 Pediatric Interventional Cardiology Devices Market, By Device Type
  • Figure 16 Other Devices
  • Figure 17 Pediatric Interventional Cardiology Devices Market, By Geography, 2013 ($Million)
  • Figure 18 Key Growth Strategies, Pediatric Interventional Cardiology Imaging Market, 2011-2014
  • Figure 19 Key Growth Strategies, Pediatric Interventional Cardiology Devices Market, 2011-2014
Back to Top